Real-time enrollment status for this lymphoblastic lymphoma clinical trial
Current Status
Recruiting
Checked: October 13, 2026 at 11:55 PM UTC
| NCT Number | NCT07586618 |
| Recruiting Status | Recruiting |
| Condition | Lymphoblastic Lymphoma |
| Phase | PHASE1 |
| Target Enrollment | 24 participants |
| Active Locations | 7 sites in the US |
| Sponsor | Allterum Therapeutics, Inc |
| Last Updated on CT.gov | September 1, 2026 (Sep 1, 2026) |
As of October 13, 2026: Clinical trial NCT07586618 is currently recruiting participants. This phase1 study for lymphoblastic lymphoma is actively seeking new participants at 7 locations across the United States. The study is sponsored by Allterum Therapeutics, Inc. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07586618 is actively recruiting participants as of October 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07586618 was last updated Sep 1, 2026 (September 1, 2026). HelloStudys verifies this status automatically.